thiophenes has been researched along with Movement Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boroojerdi, B; Fichtner, A; Giladi, N; Poewe, W | 1 |
| Fukushima, T; Hattori, H; Hoki, S; Iwakami, N; Nakada, Y; Nakagawa, M; Nakamura, A; Narita, H; Terashima, N; Yamaguchi, H | 1 |
| Catalani, A; Cianci, S; Consolazione, M; Gabriel, C; Gaetani, S; Giovine, A; Laloux, C; Maccari, S; Mairesse, J; Malagodi, M; Mazzetta, A; Mennuni, G; Mocaër, E; Morley-Fletcher, S; Nicoletti, F; Silletti, V; van Camp, G; van Reeth, O; Zuena, AR | 1 |
| Caputi, C; Galosi, S; Giannini, MT; Leuzzi, V; Mastrangelo, M | 1 |
| Behrens, S; Sommerville, K | 1 |
| Jankovic, J | 1 |
| Ghose, K | 1 |
1 review(s) available for thiophenes and Movement Disorders
| Article | Year |
|---|---|
Parkinson's disease and movement disorders: moving forward.
Topics: Dopamine Agonists; Humans; Methyldopa; Movement Disorders; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes | 2008 |
1 trial(s) available for thiophenes and Movement Disorders
| Article | Year |
|---|---|
Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson's disease.
Topics: Aged; Dopamine Agonists; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease; Prospective Studies; Sleep Wake Disorders; Tetrahydronaphthalenes; Thiophenes | 2010 |
5 other study(ies) available for thiophenes and Movement Disorders
| Article | Year |
|---|---|
T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice.
Topics: Alzheimer Disease; Animals; Cognition Disorders; Hippocampus; Maleates; Mice; Mice, Transgenic; Movement Disorders; Neuroprotective Agents; Synaptophysin; tau Proteins; Thiophenes | 2011 |
Chronic agomelatine treatment corrects the abnormalities in the circadian rhythm of motor activity and sleep/wake cycle induced by prenatal restraint stress in adult rats.
Topics: Acetamides; Analysis of Variance; Animals; Animals, Newborn; Arousal; Autoradiography; Chronobiology Disorders; Disease Models, Animal; Drug Administration Schedule; Electroencephalography; Electromyography; Female; Hippocampus; Hypnotics and Sedatives; Male; Movement Disorders; Pregnancy; Prenatal Exposure Delayed Effects; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Melatonin; Restraint, Physical; Sleep Wake Disorders; Thiophenes | 2013 |
Transdermal rotigotine in the treatment of aromatic L-amino acid decarboxylase deficiency.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Aromatic-L-Amino-Acid Decarboxylases; Child; Dopamine Agonists; Humans; Male; Movement Disorders; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2013 |
Non-oral drug delivery in Parkinson's disease: a summary from the symposium at the 7th International Congress of Parkinson's Disease and Movement Disorders. 10-14 November 2002, Miami, FL, USA.
Topics: Antiparkinson Agents; Congresses as Topic; Humans; Intestinal Absorption; Levodopa; Movement Disorders; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes | 2003 |
Pizotifen in deafferentation pain.
Topics: Afferent Pathways; Aged; Aged, 80 and over; Female; Hemiplegia; Humans; Intracranial Embolism and Thrombosis; Male; Movement Disorders; Pain; Pizotyline; Syndrome; Thalamic Diseases; Thiophenes | 1989 |